UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043266
Receipt number R000049383
Scientific Title A cross-sectional study on the significance of measuring amino acids in understanding the pathogenesis of non-alcoholic fatty liver disease
Date of disclosure of the study information 2021/02/08
Last modified on 2021/02/06 19:06:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A cross-sectional study on measuring amino acids in fatty liver

Acronym

A study to measure amino acids in fatty liver

Scientific Title

A cross-sectional study on the significance of measuring amino acids in understanding the pathogenesis of non-alcoholic fatty liver disease

Scientific Title:Acronym

A study to measure amino acids in non-alcoholic fatty liver disease

Region

Japan


Condition

Condition

non-alcoholic fatty liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To search for biomarkers of development of nonalcoholic fatty liver disease (NAFLD), we will analyze D-amino acids and L-amino acids in serum and stool of patients with NAFLD

Basic objectives2

Others

Basic objectives -Others

The identification of characteristic composition of D- and L-body amino acids in nonalcoholic fatty liver disease.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of serum and fecal amino acid concentrations between NAFLD and non-NAFLD patients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who have been diagnosed with NAFLD by histological or imaging studies within 6 months.
Patients who have not been diagnosed with NAFLD by imaging studies such as ultrasonography and MRI within 6 months.

Key exclusion criteria

Patients who have used antimicrobial agents within one month of blood and stool specimen collection
Patients who have been diagnosed with infectious hepatitis (hepatitis B or C, HIV infection), autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, hemochromatosis, alpha1-antitrypsin deficiency, Wilson's disease, drug-induced hepatitis, alcoholic hepatitis, or are known to consume excessive amounts of alcohol
Patients who are unable to collect specimens due to defecation disorder.
Patients who do not wish their medical information to be used for research purposes.
Patients who are judged by the physician to be unsuitable for the study.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Michihiro
Middle name
Last name Iwaki

Organization

Yokohama City University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

236-0004

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

0457872800

Email

michihir@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Michihiro
Middle name
Last name Iwaki

Organization

Yokohama City University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

236-0004

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa

TEL

0457872800

Homepage URL


Email

michihir@yokohama-cu.ac.jp


Sponsor or person

Institute

Department of Gastroenterology and Hepatology, Yokohama City University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Drug Discovery Department, Chemistry Research Group, EA Pharma Co., Ltd

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama city university, Institutional Review Board for Medical and Health Research Involving Human Subjects

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa

Tel

0457872640

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 02 Month 05 Day

Date of IRB

2021 Year 02 Month 05 Day

Anticipated trial start date

2021 Year 02 Month 06 Day

Last follow-up date

2026 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

study design:
Cross sectional study
Items to measure:
blood biochemical tests, urinalysis, tissue examination by liver biopsy, Liver stiffness and liver fat content by MRI, Amino acids in stool and blood, Intestinal bacteria analysis, Metabolite analysis in stool


Management information

Registered date

2021 Year 02 Month 06 Day

Last modified on

2021 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049383


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name